Evaluation of Medicare Advantage Special Needs Plans
Robert J. Schmitz, Angela Merrill, Jennifer Schore, Rachel Shapiro, Jim Verdier
Abstract
Open-access reader
Robert J. Schmitz, Angela Merrill, Jennifer Schore, Rachel Shapiro, Jim Verdier
Abstract
Open-access reader
Section 231 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) for the first time permitted Medicare Advantage (MA) plans to target beneficiaries in certain categories: institutionalized beneficiaries, those enrolled in both Medicare and Medicaid (dual eligibles), and those with severe or disabling chronic conditions.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Section 231 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) for the first time permitted Medicare Advantage (MA) plans to target beneficiaries in certain categories: institutionalized beneficiaries, those enrolled in both Medicare and Medicaid (dual eligibles), and those with severe or disabling chronic conditions.
Key concepts: Medicare Advantage, Prescription drug, Medicare Part D, Medicaid, Modernization theory, Actuarial science, Medical prescription, Multiple Chronic Conditions